38.11MMarket Cap-385P/E (TTM)
1.200High1.100Low100.63KVolume1.160Open1.150Pre Close112.74KTurnover2.69%Turnover RatioLossP/E (Static)34.65MShares7.79052wk High-0.51P/B4.11MFloat Cap0.52052wk Low--Dividend TTM3.74MShs Float26.602Historical High--Div YieldTTM8.70%Amplitude0.520Historical Low1.120Avg Price1Lot Size
Ocean Biomedical Stock Forum
Ocean Biomedical, Inc. (Nasdaq: Ocea) Announces Patent Allowance for Malaria Antibodies That Have Potential Capability to Protect Against Infection and Treat Severe Disease
NEWS
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Allowance for Malaria Antibodies That Have Potential Capability to Protect Against Infection and Treat Severe Disease
On May 16, 2024, Ocean Biomedical (NASDAQ: OCEA) announced a new patent for malaria therapeutic antibody discoveries by Dr. Jonathan Kurtis. These antibodies aim to prevent malaria infection and treat severe cases by inducing parasite death via apoptosis during a critical stage of the malaria ...
No comment yet